Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1143 | 1099 | 1143 | 1081 | 1560 | 1687 |
Fund Return | 14.34% | 9.95% | 14.34% | 2.63% | 9.3% | 5.37% |
Place in category | 62 | 86 | 62 | 18 | 6 | 8 |
% in Category | 54 | 76 | 54 | 16 | 5 | 10 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
VY T. Rowe Price Capital Apprec S | 3.95B | 2.34 | 5.06 | 10.19 | ||
Voya US Stock Index Port I | 3.92B | 5.96 | 7.77 | 12.10 | ||
Voya Growth and Income Port I | 2.24B | 7.20 | 9.57 | 11.90 | ||
VY T. Rowe Price Capital Apprec A | 1.93B | 2.23 | 4.70 | 9.80 | ||
Voya Retirement Growth Port A | 1.81B | 2.91 | 2.87 | 6.60 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
DFA International Small Company I | 11.78B | 0.67 | -0.40 | 4.58 | ||
Goldman Sachs Intl Sm Cp Insghts In | 3.2B | 3.37 | -0.76 | 4.93 | ||
Victory Trivalent International SmI | 2.84B | 2.41 | -2.25 | 5.44 | ||
Fidelity International Small Cap | 1.56B | 0.73 | 0.92 | 6.36 | ||
Fidelity Advisor International Smai | 1.22B | 0.73 | 0.92 | 6.38 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Celestica Inc Shs Sub-Voting | CA15101Q1081 | 1.25 | - | - | |
Hikma Pharma | GB00B0LCW083 | 0.97 | 1,978.00 | -0.25% | |
Pandora | DK0060252690 | 0.96 | 1,169.5 | +0.47% | |
Ipsen | FR0010259150 | 0.85 | 120.80 | -0.49% | |
iShares MSCI EAFE Small-Cap | US4642882736 | 0.84 | 64.42 | +0.26% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review